Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with highly emetogenic risk antineoplastic agents: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology
Ayako Yokomizo(Kyoto University), Masakazu Abé(Hamamatsu University School of Medicine), Kenji Okita(Otaru Municipal Hospital), Narikazu Boku(Tokyo Medical University), Takako Eguchi Nakajima(St. Marianna University School of Medicine), Mayumi Noda(Chiba University), Chiyo K. Imamura(SHOWA Medical University), Kenjiro Aogi(Shikoku Cancer Center), Ayako Okuyama(St. Luke's International University), Arisa Iba(National Center for Global Health and Medicine), Nobuyuki Yamamoto(Wakayama Medical University), Yong-il Kim(Yodogawa Christian Hospital), Hirotoshi Iihara(Gifu University Hospital), Takahiro Higashi(Unknown), Keiko Iino(National College Of Nursing), Junichi Nishimura, Kazuhisa Nakashima(Shimane University), Koji Matsumoto(WinnMed), Masayuki Takeda(Kindai University), Naoki Nakamura(St. Marianna University School of Medicine), Ryuhei Tanaka(Saitama Medical University), Yōko Matsumoto(The University of Tokyo), Keiko Ozawa(National Cancer Research Institute), Tatsuo Akechi(Nagoya City University), Kazumi Hayashi(Jikei University School of Medicine), Eriko Satomi(National Cancer Centre Japan), Hidenori Sasaki(Fukuoka University Hospital), Makoto Wada(Kitasato University)
Cited by 2
Related Papers
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k